Frontline treatment approaches in TP53-aberrant mantle cell lymphoma

Leuk Lymphoma. 2023 Jan;64(1):230-233. doi: 10.1080/10428194.2022.2131407. Epub 2022 Oct 27.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Humans
  • Lymphoma, Mantle-Cell* / diagnosis
  • Lymphoma, Mantle-Cell* / pathology
  • Lymphoma, Mantle-Cell* / therapy
  • Mutation
  • Tumor Suppressor Protein p53 / genetics

Substances

  • Tumor Suppressor Protein p53
  • TP53 protein, human